For the Inventor, By the Inventor

Enter inventor name

Mesa, AZ, United States of America

Richard V Connors

This inventor holds 19 USPTO granted patents, plus 2 CIPO patents and 6 EPO patents. Top assignee: Amgen Inc.. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard V Connors. Retrieved from https://idiyas.com/inventor/richard-v-connors

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 22.2

ph-index = 9

Forward Citations = 137(Granted Patents)

Location History:

Pacifica, CA (US) (2009 - 2016)
Scottsdale, AZ (US) (2017)
Mesa, AZ (US) (2017 - 2021)

Company Filing History:

19 out of 2,069

Years Active: 2009-2021

Loading Chart...

Loading Chart...

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11046680 - Heteroaryl-substituted triazoles as APJ receptor agonists (2021-06-29),

2. 10736883 - Triazole furan compounds as agonists of the APJ receptor (2020-08-11),

3. 10221162 - Triazole agonists of the APJ receptor (2019-03-05),

4. 10150760 - Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor (2018-12-11),

5. 9988369 - Heterocyclic triazole compounds as agonists of the APJ receptor (2018-06-05),

6. 9868721 - Triazole agonists of the APJ receptor (2018-01-16),

7. 9845310 - Intermediates for preparing triazole agonists of the APJ receptor (2017-12-19),

8. 9751864 - Methods for preparing triazole agonists of the APJ receptor (2017-09-05),

9. 9745286 - Triazole agonists of the APJ receptor (2017-08-29),

10. 9656998 - Intermediates for preparing triazole agonists of the APJ receptor (2017-05-23),

11. 9656997 - Triazole agonists of the APJ receptor (2017-05-23),

12. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2017-03-14),

13. 9573936 - Triazole agonists of the APJ receptor (2017-02-21),

14. 9376425 - Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer (2016-06-28),

15. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2016-03-29),

Title: Richard V Connors: A Pioneer in Technology and Innovation

Introduction:

Richard V Connors, a visionary inventor based in Mesa, AZ (US), continues to inspire with his inventive spirit and dedication to creating solutions that enhance our daily lives. With an impressive portfolio of 19 patents, his impact on the world of technology is truly remarkable.

Latest Patents:

His latest patents include groundbreaking inventions in the field of pharmaceuticals. Among them are "Heteroaryl-substituted triazoles as APJ receptor agonists" and "Triazole furan compounds as agonists of the APJ receptor". These compounds show promise in treating cardiovascular and other conditions, showcasing Richard's versatility and ingenuity in the realm of medical advancements.

Career Highlights:

Richard V Connors is affiliated with Amgen Inc., a renowned biotechnology company known for its innovative research and development in the healthcare industry. His presence in such a prestigious organization underscores his expertise and commitment to pushing the boundaries of science.

Collaborations:

In his professional journey, Richard has collaborated with esteemed colleagues such as Xiaodong Wang and Xiaoqi Chen. Together, they have worked on pioneering projects that have the potential to revolutionize the field of pharmaceuticals and healthcare.

Conclusion:

In conclusion, Richard V Connors stands as a beacon of inspiration in the world of technology and innovation. His relentless pursuit of excellence and passion for creating impactful solutions exemplify the true essence of an inventive mind. We look forward to witnessing more groundbreaking inventions from this visionary inventor in the future.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…